A Live Attenuated Vaccine for Lassa Fever Made by Reassortment of Lassa and Mopeia Viruses

類似資料

• Molecular characterization of a reassortant virus derived from Lassa and Mopeia viruses
  著者:: Moshkoff, Dmitry A., 等
  出版事項: (2006)
• A ML29 Reassortant Virus Protects Guinea Pigs Against a Distantly-Related Nigerian Strain of Lassa Virus and can Provide Sterilizing Immunity
  著者:: Carrion, Ricardo, 等
  出版事項: (2007)
• Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates
  著者:: Lukashevich, Igor S., 等
  出版事項: (2008)
• Transcriptome analysis of human peripheral blood mononuclear cells exposed to Lassa virus and to the attenuated Mopeia/Lassa reassortant 29 (ML29), a vaccine candidate.
  著者:: Juan Carlos Zapata, 等
  出版事項: (2013-01-01)
• Transcriptome Analysis of Human Peripheral Blood Mononuclear Cells Exposed to Lassa Virus and to the Attenuated Mopeia/Lassa Reassortant 29 (ML29), a Vaccine Candidate
  著者:: Zapata, Juan Carlos, 等
  出版事項: (2013)